Wei Shu Wang

441 total citations
12 papers, 338 citations indexed

About

Wei Shu Wang is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Wei Shu Wang has authored 12 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 3 papers in Surgery. Recurrent topics in Wei Shu Wang's work include Colorectal Cancer Treatments and Studies (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Cancer Diagnosis and Treatment (2 papers). Wei Shu Wang is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Cancer Diagnosis and Treatment (2 papers). Wei Shu Wang collaborates with scholars based in Taiwan and China. Wei Shu Wang's co-authors include Tzeon Jye Chiou, Po Min Chen, Liu H, Jen Kou Lin, Frank S. Fan, Chun Chi Lin, Ming-Yang Lee, Muh Hwa Yang, Huey‐Ling Chiang and Jun Liu and has published in prestigious journals such as Supportive Care in Cancer, Japanese Journal of Clinical Oncology and Annals of Hematology.

In The Last Decade

Wei Shu Wang

12 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Shu Wang Taiwan 8 196 123 72 59 45 12 338
Abdelmonem Elhosseiny United States 11 108 0.6× 79 0.6× 39 0.5× 55 0.9× 125 2.8× 19 335
Grace Hartman United States 11 158 0.8× 109 0.9× 137 1.9× 37 0.6× 246 5.5× 22 429
Kyoo Hyung Lee South Korea 11 116 0.6× 101 0.8× 83 1.2× 52 0.9× 51 1.1× 44 405
Rohan Mandaliya United States 10 242 1.2× 86 0.7× 30 0.4× 21 0.4× 137 3.0× 31 421
Gyula Végső Hungary 11 222 1.1× 70 0.6× 21 0.3× 52 0.9× 81 1.8× 28 379
Swetha Kambhampati United States 11 196 1.0× 34 0.3× 53 0.7× 36 0.6× 113 2.5× 29 424
Marjan Rahsaz Iran 12 77 0.4× 126 1.0× 71 1.0× 21 0.4× 97 2.2× 29 350
Andrew Watters Canada 10 92 0.5× 82 0.7× 18 0.3× 86 1.5× 33 0.7× 21 400
Taito Fukushima Japan 13 90 0.5× 122 1.0× 164 2.3× 30 0.5× 51 1.1× 43 386
Jérémy Sandrini France 10 103 0.5× 185 1.5× 94 1.3× 58 1.0× 37 0.8× 16 298

Countries citing papers authored by Wei Shu Wang

Since Specialization
Citations

This map shows the geographic impact of Wei Shu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Shu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Shu Wang more than expected).

Fields of papers citing papers by Wei Shu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Shu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Shu Wang. The network helps show where Wei Shu Wang may publish in the future.

Co-authorship network of co-authors of Wei Shu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Shu Wang. A scholar is included among the top collaborators of Wei Shu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Shu Wang. Wei Shu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lin, Jen Kou, et al.. (2011). Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study. Supportive Care in Cancer. 20(7). 1491–1497. 57 indexed citations
2.
Wang, Wei Shu, et al.. (2011). Study on the Burning Characteristics of Poor-Quality Anthracite in Supercritical W-Shaped Flame Boiler. Advanced materials research. 189-193. 1872–1877. 7 indexed citations
3.
Chiou, Tzeon Jye, et al.. (2008). High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin’s lymphoma. Annals of Hematology. 87(6). 475–480. 90 indexed citations
4.
Lee, Ming-Yang, Tzeon Jye Chiou, Muh Hwa Yang, et al.. (2007). Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic stem cell transplantation. Annals of Hematology. 87(4). 285–289. 47 indexed citations
6.
Wang, Wei Shu, Jen Kou Lin, Tzeon Jye Chiou, et al.. (2002). CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.. PubMed. 49(43). 160–4. 51 indexed citations
7.
Wang, Wei Shu. (1997). High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma. Japanese Journal of Clinical Oncology. 27(3). 154–157. 31 indexed citations
8.
Wang, Wei Shu. (1997). Factors predictive of response and survival in patients with metastatic colorectal cancer in Taiwan. Japanese Journal of Clinical Oncology. 27(3). 174–179. 3 indexed citations
9.
Wang, Wei Shu. (1997). Langerhans' cell histiocytosis with thyroid involvement masquerading as thyroid carcinoma. Japanese Journal of Clinical Oncology. 27(3). 180–184. 14 indexed citations
10.
Wang, Wei Shu, et al.. (1996). High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma.. PubMed. 57(2). 100–5. 2 indexed citations
11.
Wang, Wei Shu, et al.. (1996). Non-small cell lung cancer with testicular metastasis: a case report.. PubMed. 58(1). 54–7. 5 indexed citations
12.
Wang, Wei Shu, et al.. (1996). Signet-ring cell carcinoma of the rectum with tonsillar metastasis: a case report.. PubMed. 58(3). 209–12. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026